| Argo Global Listed Infrastructure Limited (ALI) ORDINARY FULLY PAID |
Financials |
$443 |
Quarterly Investment Update - 31 March 2026
|
29 Apr 2026 10:54AM |
$2.390 |
$2.490 |
risen by
4.18%
|
|
| SQX Resources Limited (SQX) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 10:53AM |
$0.100 |
$0.067 |
fallen by
33%
|
|
SQX - Price-sensitive ASX Announcement
Full Release
Key Points
- USA portfolio acquisition completed, securing interests in Red Bird (Arizona) and Williams (Montana) projects.
- Permitting secured at Red Bird, enabling maiden RC drilling program.
- Maiden drilling at Red Bird executed with exceptional results indicating substantial shallow gold system.
- Spectacular channel sampling at Red Bird confirmed high-grade, wide results.
- Expansion of Williams ground with 25 new claims staked.
- Leadership strengthened with new executive appointments.
- Cash balance of $1.27M as of 31 March 2026.
- Payments for exploration and evaluation and administrative costs detailed in the report.
- Net cash used in operating and investing activities reported, with funding covering less than one quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$312 |
Notification of cessation of securities - PAC
|
29 Apr 2026 10:49AM |
$10.430 |
$10.880 |
risen by
4.31%
|
|
| Platformo Ltd (PFM) ORDINARY FULLY PAID |
Information Technology |
$3 |
Notice of Annual General Meeting and Proxy Form
|
29 Apr 2026 10:48AM |
$0.031 |
$0.030 |
fallen by
3.23%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$11 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2026 10:45AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
ADR - Price-sensitive ASX Announcement
Full Release
Key Points
- Adherium Limited released its Quarterly Activities/Appendix 4C Cash Flow Report for the period ending 31 March 2026.
- Operating cash flows showed a net decrease, with receipts from customers totaling $228,000 and significant expenditures on research, development, and staff costs.
- Government grants and tax incentives contributed $887,000 to cash inflows.
- Investing activities resulted in a minor cash outflow of $11,000, primarily from property and equipment purchases.
- Financing activities provided a net cash inflow of $5,886,000 driven by equity issues and borrowings.
- Cash and cash equivalents increased to $2,956,000 by quarter-end.
- Adherium’s Hailie platform is being integrated with various healthcare networks, expanding its RPM partnerships and client base.
- Adherium anticipates further growth and sustainability through enhanced reimbursement capabilities and strategic partnerships.
- The company remains focused on optimizing its technology and expanding its presence in value-based care markets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conrad Asia Energy Ltd (CRD) CHESS DEPOSITARY INTERESTS 1:1 |
Energy |
$87 |
Quarterly Activities Report and Appendix 5B - Q1
|
29 Apr 2026 10:43AM |
$0.500 |
$0.450 |
fallen by
10%
|
|
CRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Conrad Asia Energy Ltd executed the NNB PI Transfer, triggering a receipt of US$5 million out of the agreed US$16 million.
- The company announced its Final Investment Decision (FID) for the Mako Gas Project is set for development.
- The Mako project involves two phases with a significant part of the capital contracts awarded by the end of Q1 2026.
- Conrad reported an increase in 1P and 2P reserves for the Mako project and secured funding.
- An upcoming seismic acquisition program in ONWA is scheduled for Q3 2026.
- Net cash flow from operating activities was negative US$1.635 million for the quarter.
- The company recorded a closing cash balance of US$5.298 million at the end of the quarter.
- No environmental incidents were reported in the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mithril Silver and Gold Limited (MTH) ORDINARY FULLY PAID |
Materials |
$64 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 10:41AM |
$0.320 |
$0.340 |
risen by
6.25%
|
|
MTH - Price-sensitive ASX Announcement
Full Release
Key Points
- Systematic advancement of exploration targets in Copalquin District.
- Successful drilling at Targets 3 and 5 highlighting gold and silver potential.
- Phase IV drilling at Target 1 extended El Refugio's strike length.
- Appointment of James Barr as Vice President of Exploration to enhance leadership.
- Cash balance of A$10.8M and debt-free status reported for March 2026.
- Continued Mexican VAT refunds contributing to financials.
- A$2.86M spent on exploration during the quarter, focused on Copalquin District.
- Appendix 5B reports cash expenditures and related party payments.
- Planned exploration activities for June 2026 include drilling and geological studies.
- Recent drill results confirm high-grade mineralization potential at several targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ronin Resources Ltd (RON) ORDINARY FULLY PAID |
Materials |
$7 |
RON March 2026 Quarterly Activities Report & Appendix 5B
|
29 Apr 2026 10:37AM |
$0.165 |
$0.175 |
risen by
6.06%
|
|
RON - Price-sensitive ASX Announcement
Full Release
Key Points
- Continued exploration at La Punilla project, Argentina
- Geological mapping, rock-chip sampling, and aeromagnetic survey conducted
- No agreements reached on potential acquisition opportunities
- Cash reserves at $2.895 million as of 31 March 2026
- No net cash flow from financing activities this quarter
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$17 |
Response to ASX Price Query
|
29 Apr 2026 10:34AM |
$0.028 |
$0.015 |
fallen by
46.43%
|
|
LSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Lodestar Minerals Limited responded to ASX price query.
- Drilling programs underway at Three Saints and Ned’s Creek.
- Visible sulphide mineralization observed at Three Saints.
- Samples sent for assay from both projects.
- Assay results from Three Saints expected in three weeks.
- Ned’s Creek assay results expected every two weeks for two months.
- Company assured compliance with ASX Listing Rules.
- Board-approved responses to ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lodestar Minerals Limited (LSR) ORDINARY FULLY PAID |
Materials |
$17 |
Visible Copper and IOCG Mineralisation Confirmed in Chile
|
29 Apr 2026 10:34AM |
$0.028 |
$0.015 |
fallen by
46.43%
|
|
LSR - Price-sensitive ASX Announcement
Full Release
Key Points
- Visible copper observed in second drill hole L3SDD004.
- Drilling at Three Saints IOCG Project in Chile.
- IOCG-style mineralised system confirmed.
- 700m strike length of mineralisation indicated.
- Hydrothermal alteration and sulphides present.
- Results from drill holes expected end of May and early July.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$99 |
Notification of cessation of securities - CAM
|
29 Apr 2026 10:33AM |
$0.700 |
$0.700 |
fallen by
0%
|
|
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Letter to Shareholders
|
29 Apr 2026 10:30AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
| Perseus Mining Limited (PRU) ORDINARY FULLY PAID |
Materials |
$6,927 |
Update - Notification of buy-back - PRU
|
29 Apr 2026 10:29AM |
$5.520 |
$5.170 |
fallen by
6.34%
|
|
| Hydrocarbon Dynamics Limited (HCD) ORDINARY FULLY PAID |
Energy |
$0 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 10:28AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Winchester Energy Limited (WEL) ORDINARY FULLY PAID |
Energy |
$3 |
Notice of AGM
|
29 Apr 2026 10:27AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
| Revolver Resources Holdings Ltd (RRR) ORDINARY FULLY PAID |
Materials |
$21 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 10:22AM |
$0.071 |
$0.069 |
fallen by
3.52%
|
|
RRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report for the period ended 31 March 2026.
- Focus on the Dianne Copper Mine Project with pre-construction activities completed.
- Successful capital raising of approximately A$2.6 million.
- Cash outflows included exploration and evaluation expenditure and administrative costs.
- Revolver had approximately A$1.219 million in cash at the end of March 2026.
- Targeting a final investment decision on the Dianne project with copper output expected within 12 months following the decision.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$51 |
Proposed issue of securities - SNT
|
29 Apr 2026 10:21AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$51 |
Proposed issue of securities - SNT
|
29 Apr 2026 10:21AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$51 |
Equity Raising Presentation
|
29 Apr 2026 10:21AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Syntara Limited is conducting a two tranche non-underwritten placement to raise approximately A$8 million.
- The placement includes issuing approximately 296.3 million new fully paid ordinary shares.
- The offer price is set at A$0.027 per new share, representing a discount to recent trading prices and VWAPs.
- Funds raised will be used for trial readouts, MF licensing discussions, and Phase 2b MF study preparations.
- Canaccord Genuity and Euroz Hartleys are acting as Joint Lead Managers and Joint Bookrunners.
- The company’s pipeline includes assets such as Amsulostat, SNT-4728, and SNT-9465.
- Syntara aims to leverage its assets to negotiate licensing deals within the financial runway provided by the raise.
- The company has FDA IND and orphan drug designation for Amsulostat in myelofibrosis.
- Preparations are underway for a Phase 2b study expected to commence in Q4 2026.
- Syntara's business is backed by specialist healthcare investors and has a strong track record in asset partnerships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$51 |
$8m placement and share purchase plan
|
29 Apr 2026 10:21AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Syntara Limited announced a capital raising of A$8 million via institutional placement.
- An additional A$2 million is aimed to be raised through a share purchase plan (SPP).
- The funds will support clinical trial programs and preparatory work for a Phase 2b study.
- Placement was divided into two tranches, with settlement dates in May and June 2026.
- The placement price was set at A$0.027 per share, at a discount to recent trading prices.
- Strong support was received from existing and new institutional investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atomos Limited (AMS) ORDINARY FULLY PAID |
Consumer Discretionary |
$25 |
NAB 2026 Product and Ecosystem Update
|
29 Apr 2026 10:18AM |
$0.021 |
$0.017 |
fallen by
19.05%
|
|
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$295 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2026 10:15AM |
$0.705 |
$0.700 |
fallen by
0.71%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA alignment confirmed for DEP® HER2 first-in-human phase 1 clinical study.
- Strategic partnerships and platform validation advanced through engagements at JP Morgan and BIO-Europe.
- Publication of research collaboration with Genentech in the Journal of Pharmaceutical Sciences.
- Preparation for first-in-human phase 1 study of DEP® HER2 radiotherapeutic candidate.
- Starpharma's cash balance was $14.1 million as of 31 March 2026.
- Net operating cash outflows for the quarter were $3.9 million.
- Continued commercial activities for Viraleze™ with an increase in web sales.
- Presented at the Ignite Investment Summit in Hong Kong.
- Estimated quarters of funding available is 3.7 quarters.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$36 |
Trading Halt
|
29 Apr 2026 10:14AM |
$0.345 |
$0.300 |
fallen by
13.04%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies Limited (ASX: SPN) requested a trading halt.
- The trading halt will remain in place until either the commencement of normal trading on Friday, 1 May 2026, or until the release of an announcement.
- The trading halt is requested to manage continuous disclosure obligations.
- The purpose of the halt is related to a material update concerning ecosparc®.
- The company expects to make the announcement before the commencement of normal trading on the mentioned date.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rivco Australia Ltd (RIV) ORDINARY FULLY PAID |
Utilities |
$227 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2026 10:11AM |
$1.450 |
$1.430 |
fallen by
1.38%
|
|
RIV - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating receipts totaled $4.4 million for the quarter.
- Staff costs were $0.21 million, and administration and corporate costs were $0.49 million.
- Investing cash outflows of $2.2 million for acquiring water entitlements.
- Financing cash outflows included a $2.0 million debt repayment.
- Net cash from operating activities was $3.223 million.
- Net decrease in cash and cash equivalents for the period was $2.531 million.
- Cash and cash equivalents at the end of the period were $1.5 million.
- The company had $20.5 million of debt drawn under its $40.0 million facility.
- A fully franked dividend of 3.72 cents per share was declared.
- Strategic priorities include increasing earnings stability and portfolio optimization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Otto Energy Limited (OEL) ORDINARY FULLY PAID |
Energy |
$24 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 10:05AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
OEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Green #1 well performed as expected, while Green #2 experienced an increased water-to-gas ratio.
- Production from Green #1 and #2 was 58.8 Mboe, a 10% decrease from the previous quarter.
- Revenue increased by 10% due to higher natural gas and oil prices.
- Production and sales revenue details for SM 71 and Lightning projects are provided.
- Financial outcomes impacted by price changes in commodities market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
